Oral Cyanocobalamin Treatment in Infants Under 1 Year With Nutritional Vitamin B12 Deficiency: A Retrospective Comparison of 500 and 1000 µg Dose Regimens
- 3 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (7) , e323-e328
Abstract
Background: Vitamin B12 deficiency is a significant health problem in infancy, particularly in developing countries. Oral treatment has emerged as an alternative to intramuscular therapy, but optimal dosing in infants remains unclear. Methods: This retrospective study included 93 infants aged 1 to 12 months diagnosed with nutritional vitamin B12 deficiency. Patients received either 500 or 1000 µg oral cyanocobalamin. Laboratory parameters were evaluated at baseline, 2 months, and 4 months. Results: Both treatment groups demonstrated significant increases in serum vitamin B12 levels and decreases in homocysteine levels ( P <0.001). No significant difference was observed between the 500 and 1000 µg groups regarding hematological or biochemical response. Treatment was well tolerated with no reported adverse effects. Conclusions: Oral cyanocobalamin was associated with biochemical improvement and was well tolerated in infants under 1 year of age. Although no significant difference was observed between the 500 and 1000 µg regimens in this retrospective cohort, prospective noninferiority studies are needed to determine whether the lower dose is comparable with the higher dose.Keywords
This publication has 18 references indexed in Scilit:
- Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort studyThe American Journal of Clinical Nutrition, 2024
- Efficacy of oral methylcobalamin in treatment of vitamin B12 deficiency anemia in childrenPediatric Blood & Cancer, 2017
- Addition of Cobalamin to Iron and Folic Acid Improves Hemoglobin Rise in Nutritional AnemiaIndian Journal of Pediatrics, 2012
- Comparing the Efficacy and Tolerability of a New Daily Oral Vitamin B12 Formulation and Intermittent Intramuscular Vitamin B12 in Normalizing Low Cobalamin Levels: A Randomized, Open-Label, Parallel-Group StudyClinical Therapeutics, 2011
- Clinical presentation and metabolic consequences in 40 breastfed infants with nutritional vitamin B12 deficiency – What have we learned?European Journal of Paediatric Neurology, 2010
- Is Oral Vitamin B 12 Therapy Effective for Vitamin B 12 Deficiency in Patients With Prior Ileocystoplasty?Journal of Urology, 2010
- Oral versus intramuscular cobalamin treatment in megaloblastic anemia: A single-center, prospective, randomized, open-label studyClinical Therapeutics, 2003
- Homocysteine and Neurologic DiseaseArchives of Neurology, 2000
- Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficienciesThe American Journal of Medicine, 1994
- Long-term neurologic consequences of nutritional vitamin B12 deficiency in infantsThe Journal of Pediatrics, 1992